Terms ending in 2033

Array Biopharma Inc.

Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.

Patent	Title	Holder	Status	Expires	Confidence
US 9,278,936	Crystalline Forms of 1-(3-TERT-BUTYL-1-P-TOLYL-1H-PYRAZOL-5-YL)-3-(5-Fluoro-2-(1-(2-Hydroxyethyl)-INDAZOL-5-Yloxy)BENZYL)UREA Hydrochloride Array Biopharma, Inc. In force Term ends Feb 27, 2033 · High confidence	Array Biopharma, Inc.	In force	Term ends Feb 27, 2033	High confidence
US 9,259,470	Serine/Threonine Kinase Inhibitors Array Biopharma, Inc. In force Term ends Mar 1, 2033 · High confidence	Array Biopharma, Inc.	In force	Term ends Mar 1, 2033	High confidence
US 9,708,290	Serine/Threonine Kinase Inhibitors Array Biopharma, Inc. In force Term ends Mar 1, 2033 · High confidence	Array Biopharma, Inc.	In force	Term ends Mar 1, 2033	High confidence
US 10,519,126	Serine/Threonine Kinase Inhibitors Array BioPharma Inc. In force Term ends Mar 1, 2033 · High confidence	Array BioPharma Inc.	In force	Term ends Mar 1, 2033	High confidence
US 11,007,194	Method of Treating a Proliferative Disease Array Biopharma Inc. In force Term ends Mar 10, 2033 · High confidence	Array Biopharma Inc.	In force	Term ends Mar 10, 2033	High confidence
US 11,504,370	Treatment of Brain Cancer Array Biopharma Inc. In force Term ends Mar 25, 2033 · High confidence	Array Biopharma Inc.	In force	Term ends Mar 25, 2033	High confidence
US 9,309,204	Process for Making Hydroxylated Cyclopentylpyrimidine Compounds Array BioPharma Inc. In force Term ends May 17, 2033 · High confidence	Array BioPharma Inc.	In force	Term ends May 17, 2033	High confidence
US 9,416,110	Process for Making Hydroxylated Cyclopentylpyrimidine Compounds Genentech, Inc. In force Term ends May 17, 2033 · High confidence	Genentech, Inc.	In force	Term ends May 17, 2033	High confidence
US 9,676,730	Process for Making Hydroxylated Cyclopentylpyrimidine Compounds Genentech, Inc. In force Term ends May 17, 2033 · High confidence	Genentech, Inc.	In force	Term ends May 17, 2033	High confidence
US 9,790,190	Process for Making Hydroxylated Cyclopentylpyrimidine Compounds Genentech, Inc. In force Term ends May 17, 2033 · High confidence	Genentech, Inc.	In force	Term ends May 17, 2033	High confidence
11 more term ends in 2033 · Pro

10 of 21 patents shown. Soonest term end first, then patent number.

Pro members see all 21.

Upgrade to Pro

18 of these are in force and held by Array Biopharma Inc..

Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.